William C. Olson

14.0k total citations · 1 hit paper
142 papers, 7.7k citations indexed

About

William C. Olson is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Virology. According to data from OpenAlex, William C. Olson has authored 142 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Radiology, Nuclear Medicine and Imaging, 53 papers in Immunology and 48 papers in Virology. Recurrent topics in William C. Olson's work include HIV Research and Treatment (48 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Immune Cell Function and Interaction (27 papers). William C. Olson is often cited by papers focused on HIV Research and Treatment (48 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Immune Cell Function and Interaction (27 papers). William C. Olson collaborates with scholars based in United States, Netherlands and France. William C. Olson's co-authors include Paul J. Maddon, John P. Moore, Tatjana Dragic, James Μ. Binley, Alexandra Trkola, Rogier W. Sanders, Graham P. Allaway, James E. Robinson, Cecilia Cheng‐Mayer and James Arthos and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

William C. Olson

137 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

1996 922 citations Alexandra Trkola, James Μ. Binley et al. profile →

Peers

Countries citing papers authored by William C. Olson

Since Specialization

Citations

This map shows the geographic impact of William C. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Olson more than expected).

Fields of papers citing papers by William C. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Olson. The network helps show where William C. Olson may publish in the future.

Co-authorship network of co-authors of William C. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Olson. A scholar is included among the top collaborators of William C. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Olson. William C. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants 2024 ·Cancer Research ·(unknown), (unknown), Zaoli Jiang, (unknown), Michael Rosconi, Bojie Zhang, Yinyin Li, Drew Dudgeon, Changhyun Seong, (unknown), Ashique Rafique, Tammy Huang, (unknown), Pamela Krueger, Erica Ullman, William C. Olson, (unknown), (unknown), Christopher Daly	3
2	Structural insights into CXCR4 modulation and oligomerization 2024 ·Nature Structural & Molecular Biology ·Kei Saotome, Luke L. McGoldrick, (unknown), Trudy F. Ramlall, (unknown), Michael J. Moore, Jee Hae Kim, Raymond Leidich, William C. Olson, Matthew C. Franklin	17
3	Structural Analysis of Cancer-relevant TCR-CD3 and Peptide-MHC Complexes by CryoEM 2023 ·Microscopy and Microanalysis ·Kei Saotome, Drew Dudgeon, (unknown), Michael J. Moore, Jennifer L. Jones, Yi Zhou, Ashique Rafique, George D. Yancopoulos, Andrew Murphy, John Lin, William C. Olson, Matthew C. Franklin	3
4	The impact of different human IgG capture molecules on the kinetics analysis of antibody-antigen interaction 2020 ·Analytical Biochemistry ·Vishal Kamat, Ashique Rafique, Tammy Huang, Olav Olsen, William C. Olson	25
5	A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models 2019 ·Clinical Cancer Research ·John O. DaSilva, (unknown), Andrés E. Perez Bay, Julian Andreev, (unknown), Erica Pyles, Matthew C. Franklin, Drew Dudgeon, Ashique Rafique, Anthony Doré, Frank J. Delfino, Terra Potocky, Robert Babb, Gang Chen, Douglas MacDonald, William C. Olson, Gavin Thurston, Christopher Daly	23
6	Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3 –Knockin Mice 2019 ·Molecular Cancer Therapeutics ·Elena Burova, Aynur Hermann, Jie Dai, Erica Ullman, Gábor Halász, Terra Potocky, (unknown), Matt Liu, (unknown), Amy Woodruff, (unknown), Ashique Rafique, William Poueymirou, Joel Martin, Douglas MacDonald, William C. Olson, Andrew Murphy, Ella Ioffe, Gavin Thurston, Markus Mohrs	62
7	Wild Type and Mutant Retinoschisin Subunits Co-assemble When Expressed in the Same Cells 2018 ·Investigative Ophthalmology & Visual Science ·(unknown), Yang Liu, (unknown), Jifang Tao, Joel Martin, William C. Olson, Jingtai Cao, Carmelo Romano	1
8	Erratum: Opportunities for therapeutic antibodies directed at G-protein-coupled receptors 2017 ·Nature Reviews Drug Discovery ·Catherine J. Hutchings, Markus Koglin, William C. Olson, Fiona H. Marshall	36
9	Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection 2015 ·Proceedings of the National Academy of Sciences ·Kristen E. Pascal, Christopher M. Coleman, Alejandro O. Mujica, Vishal Kamat, Ashok Badithe, Jeanette Fairhurst, Charleen Hunt, (unknown), (unknown), Jeanne M. Sisk, Krystal Matthews, Robert Babb, Gang Chen, (unknown), Tammy Huang, William C. Olson, George D. Yancopoulos, Neil Stahl, Matthew B. Frieman, Christos A. Kyratsous	172
10	Antibody-drug conjugates targeting prostate-specific membrane antigen 2014 ·Frontiers in bioscience ·William C. Olson	13
11	Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers 2012 ·Journal of Biological Chemistry ·Rafael S. Depetris, Jean‐Philippe Julien, Reza Khayat, Jeong Hyun Lee, Robert Pejchal, Umesh Katpally, (unknown), (unknown), (unknown), (unknown), Albert Cupo, Andre J. Marozsan, William C. Olson, Andrew B. Ward, Ian A. Wilson, Rogier W. Sanders, John P. Moore	40
12	Silicon micromachined ultrasonic transducer for cutting applications with improved power transfer 2012 ·Infoscience (Ecole Polytechnique Fédérale de Lausanne) ·(unknown), Robert Lockhart, D. Briand, Don Isarakorn, (unknown), (unknown), J. Brossard, H. Keppner, William C. Olson, (unknown), Ν. F. de Rooij, (unknown)	1
13	Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses 2011 ·Journal of Virology ·Mark Melchers, Ilja Bontjer, Tommy Tong, Nancy P. Y. Chung, Per Johan Klasse, Dirk Eggink, David C. Montefiori, (unknown), Andrea Cerutti, William C. Olson, Ben Berkhout, James Μ. Binley, John P. Moore, Rogier W. Sanders	39
14	In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen 2011 ·Molecular Cancer Therapeutics ·Xinning Wang, Dangshe Ma, William C. Olson, Warren D.W. Heston	93
15	Purified, Proteolytically Mature HIV Type 1 SOSIP gp140 Envelope Trimers 2007 ·AIDS Research and Human Retroviruses ·Sai Prasad N. Iyer, Michael Franti, (unknown), (unknown), (unknown), Kenneth H. Roux, (unknown), Antu Dey, Simon Beddows, Paul J. Maddon, John P. Moore, William C. Olson	19
16	The CCR5 mAb PRO 140 and Small-Molecule CCR5 Antagonists Possess Complementary HIV-1 Resistance Profiles 2006 ·William C. Olson	1
17	A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120 2006 ·Virology ·Simon Beddows, Michael Franti, Antu Dey, Marc W. Kirschner, Sai Prasad N. Iyer, (unknown), (unknown), Eloísa Yuste, Ronald C. Desrosiers, Per Johan Klasse, Paul J. Maddon, William C. Olson, John P. Moore	84
18	In Vivo Efficacy of Anti-Glycoprotein 41, But Not Anti-Glycoprotein 120, Immunotoxins in a Mouse Model of HIV Infection 2003 ·The Journal of Immunology ·Seth H. Pincus, Fang Hua, Royce A. Wilkinson, (unknown), James E. Robinson, William C. Olson	48
19	A Modified SCID Mouse Model of HIV Infection with Utility for Testing Anti-HIV Therapies 2003 ·AIDS Research and Human Retroviruses ·Seth H. Pincus, Fang Hua, Royce A. Wilkinson, William C. Olson, (unknown)	5
20	Single‐Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV‐Infected Adults 2000 ·The Journal of Infectious Diseases ·Jeffrey M. Jacobson, Israel Lowy, Courtney V. Fletcher, (unknown), Diep N. H. Tran, Thomas J. Ketas, Alexandra Trkola, Mary E. Klotman, Paul J. Maddon, William C. Olson, Robert J. Israel	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact